Identification and Ablation of Dormant Conduction in Atrial Fibrillation Using Adenosine

Area of Science:

• Electrophysiology
• Cardiovascular Medicine
• Medical Interventions

Background:

• Atrial fibrillation (AF) ablation is a common treatment, but recurrences are frequent.
• Dormant conduction is a suspected cause of AF recurrence after ablation.
• The role of adenosine in identifying and ablating these dormant pathways remains controversial.

Purpose of the Study:

• To evaluate the efficacy of adenosine in reducing AF recurrence after ablation.
• To compare adenosine use versus no adenosine use in AF ablation outcomes.
• To analyze the impact of adenosine administration timing and type on AF recurrence.

Main Methods:

• A meta-analysis was conducted on human studies comparing AF ablation with and without adenosine or adenosine triphosphate (ATP).
• Studies included reported freedom from AF at a minimum 6-month follow-up.
• Subgroup analyses examined ablation modality, adenosine preparation, and administration timing.

Main Results:

• Adenosine use was associated with a decrease in AF recurrence compared to controls.
• No significant difference in AF recurrence was observed based on ablation modality (cryoablation vs. radiofrequency ablation) or adenosine preparation (ATP vs. adenosine).
• Delayed ATP administration demonstrated a significant benefit over early administration; however, pooling randomized controlled trials did not reveal a significant difference in AF recurrence.

Conclusions:

• Adenosine-guided identification and ablation of dormant pathways may decrease AF recurrence.
• Optimizing adenosine administration timing could be crucial for improving ablation outcomes.
• Further research, particularly large randomized trials, may be needed to clarify the definitive role of adenosine in AF ablation.